Japan, China, Korea And ASEAN Countries Agree To Increase Tamiflu Stockpile
This article was originally published in PharmAsia News
Executive Summary
Health ministers from 10 ASEAN countries and Japan, China, Korea agreed May 8 to increase Tamiflu (oseltamivir) stockpiles. The ministers acknowledged that the avian flu virus H5N1 is still a large health threat to the region. The meeting also mentioned that 90 percent of flu drugs and vaccine production are concentrated in the U.S. and Europe, and effectively securing a drug supply remained a major problem. (Click here for more - Japanese languageYou may also be interested in...
EMA Prepares Approval Verdict On Beovu, Idhifa, Recarbrio
Products from Novartis, Celgene and Merck could get an EU approval recommendation at this week's CHMP meeting.
New Zealand Reverse-Switches Codeine Judging Risks Outweigh Benefits
New Zealand is the latest country to reverse-switch all codeine-containing OTC drugs to prescription-only status following a protracted consultation process, during which industry's protestations fell on deaf ears.
Julphar Focuses On Quality As Carle Departs
As its CEO Jerome Carle steps down following a 67% slump in sales to date this year, UAE-based Julphar is hopeful of putting manufacturing problems behind it under a new management team.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports